| Members |
targetComponentId |
| Gliding bacteria |
Non-photosynthetic, non-fruiting gliding bacteria |
| Glioblastoma - category |
Glioblastoma |
| glioblastome |
Glioblastoma |
| Glipizide 10mg m/r tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 10mg prolonged-release oral tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 2.5mg m/r tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 2.5mg prolonged-release oral tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 5mg m/r tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Glipizide 5mg prolonged-release oral tablet |
Product containing only glipizide in oral dose form (medicinal product form) |
| Globus abdominalis |
Functional bloating (disorder) |
| Glomus jugulare tumor |
Malignant glomus jugulare tumor |
| néoplasme glomique de la mastoïde |
Benign glomus tumor of mastoid |
| tumeur glomique |
Benign glomus tumour |
| Glomus tumor |
Benign glomus tumour |
| néoplasme glomique de l'oreille |
Benign glomus tumor of ear (disorder) |
| néoplasme glomique de la peau |
Benign glomus tumor of skin |
| Glomus tumour |
Benign glomus tumour |
| néoplasme glomique du nerf vague |
Malignant vagal paraganglioma (disorder) |
| Glottis TNM finding |
American Joint Committee on Cancer allowable value |
| glucagonome |
Malignant glucagonoma of pancreas (disorder) |
| Glucagonoma |
Glucagonoma, malignant |
| Glucagonoma of uncertain behavior |
Malignant glucagonoma of pancreas (disorder) |
| Glucagonoma of uncertain behavior |
Glucagonoma, malignant |
| Gluconobacter oxydans subspecies industrius |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies melanogenes |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies oxydans |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies sphaericus |
Gluconobacter oxydans (organism) |
| Gluconobacter oxydans subspecies suboxydans |
Gluconobacter oxydans (organism) |
| Glucose 10% infusion solution bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 15% infusion solution bottle |
Product containing precisely glucose 150 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 20% infusion solution 500 mL polyethylene bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 20% infusion solution bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 40% infusion solution bottle |
Glucose 400 mg/mL solution for injection |
| Glucose 50% infusion solution bottle |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 50% injection solution prefilled syringe |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose 70% infusion solution bag |
Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Glucose in sample |
Glucose level - finding |
| Glucose tolerance test NOS |
Measurement of blood glucose in the fasting state and at specific intervals before and after oral or intravenous glucose load to determine the ability to maintain homeostasis of glucose. |
| Glucose tolerance test NOS |
Measurement of blood glucose in the fasting state and at specific intervals before and after oral or intravenous glucose load to determine the ability to maintain homeostasis of glucose. |
| Gluma - Dentine bonding agent |
Dentine bonding agent |
| Gluphosphate causing toxic effect |
Glyphosate toxicity |
| Glycerin 10% conventional release eye drops |
Glycerol 10 mg/mL eye solution |
| Glycerin 10% preservative-free eye drops |
Glycerol 10 mg/mL eye solution |
| Glycerin 20% conventional release eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 20% preservative-free eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 30% conventional release eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 30% preservative-free eye drops |
Product containing only glycerol in ocular dose form (medicinal product form) |
| Glycerin 50% conventional release eye drops |
Glycerol 500 mg/mL eye solution |
| Glycerin 50% preservative-free eye drops |
Glycerol 500 mg/mL eye solution |
| Glycerin 50% solution |
Glycerol only product |
| Glycerol 1g infant suppository |
Product containing precisely glycerol 1 gram/1 each conventional release rectal suppository (clinical drug) |
| Glycerol 2g child suppository |
Glycerol 2 g rectal suppository |
| Glycerol 4g adult suppository |
Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug) |
| Glycerol kinase deficiency |
Deficiency of glycerol kinase (disorder) |
| Mikrodeletionssyndrom Xp21 |
A rare chromosomal anomaly with characteristics of complex glycerol kinase deficiency, congenital adrenal hypoplasia, intellectual disability and/or Duchenne muscular dystrophy that usually affect males. The clinical features depend on the deletion size and the number and type of involved genes. |
| Glyceryl trinitrate 0.4% ointment |
Product containing only glyceryl trinitrate (medicinal product) |
| Glyceryl trinitrate 2mg m/r buccal tablet |
Glyceryl trinitrate 2 mg buccal tablet |
| Glyceryl trinitrate 3mg m/r buccal tablet |
Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
| Glyceryl trinitrate 5mg m/r buccal tablet |
Glyceryl trinitrate 5 mg buccal tablet |
| Glyceryl trinitrate spray allergy |
Allergy to nitroglycerin |
| Glycosidase |
Glycosidase (substance) |
| glycosurie pendant la grossesse avec complication postnatale |
Pregnancy-related glycosuria |
| Glycosyltransferase |
Glycosyltransferase |
| Goat's milk |
Goat's milk |
| Goldberg-Maxwell syndrome |
A rare difference of sex development (DSD) characterised by the presence of female external genitalia, ambiguous genitalia or variable defects in virilisation in a 46,XY individual with absent or partial responsiveness to age-appropriate levels of androgens. It comprises two clinical subgroups: complete AIS (CAIS) and partial AIS (PAIS). |
| Gomphocarpus physocarpus |
Asclepias physocarpus |
| Gomphrena physocarpus |
Asclepias physocarpus |
| Gonadal dysgenesis NOS |
Gonadal dysgenesis |
| Gonadal dysgenesis NOS |
Gonadal dysgenesis |
| Gonadotrophin levels NOS |
Pituitary gonadotropin measurement |
| Gonadotrophin levels NOS |
Pituitary gonadotropin measurement |
| gonorrhée avec complication locale |
Gonorrhea |
| hémipelvectomie de Gordon-Taylor |
Amputation of entire lower limb and half of pelvis on the same side. |
| Gorissenne's sign |
Jorissenne sign |
| Goura cristata cristata |
Goura cristata (organism) |
| Gout monitoring NOS |
Gout monitoring |
| Gout monitoring NOS |
Gout monitoring |
| Gout with other manifestation, NEC |
A disease caused by monosodium urate crystal deposition with any of the following clinical presentations (current or prior): gout flare, chronic gouty arthritis, or subcutaneous tophus. |
| Gouty arthritis NOS |
Gouty arthritis |
| Gouty nephropathy NOS |
Chronic gouty nephropathy |
| Gouty nephropathy unspecified |
Chronic gouty nephropathy |
| Grade of dysplasia of adenoma at surgical proximal margin |
Histologic grade of dysplasia at proximal surgical margin |
| valeurs de classification |
Grades |
| Graft to organ NOC |
A surgical technique in which tissues, cells, or synthetic material, commonly from the same person, another individual, or an animal, are transferred to a recipient site. Grafts of skin and tissue fragments that are completely detached from their original source typically lack their own intrinsic blood supply and rely on the recipient site for vascular perfusion and survival. While solid organs are almost exclusively transplanted and skin and tissues are generally grafted, the terms graft and transplant are sometimes used interchangeably depending on the context and medical specialty. |
| Graft to organ NOC NOS |
A surgical technique in which tissues, cells, or synthetic material, commonly from the same person, another individual, or an animal, are transferred to a recipient site. Grafts of skin and tissue fragments that are completely detached from their original source typically lack their own intrinsic blood supply and rely on the recipient site for vascular perfusion and survival. While solid organs are almost exclusively transplanted and skin and tissues are generally grafted, the terms graft and transplant are sometimes used interchangeably depending on the context and medical specialty. |
| Grafting of bone, autogenous or bone bank |
Bone graft |
| Grafting of mucosa to head or neck |
Reconstruction of head and/or neck with mucosal graft |
| Grafting of nasolabial flaps |
Reconstruction using nasolabial flap of skin (procedure) |
| Grafting of pedicle fascial flap |
Reconstruction using pedicle fascial flap (procedure) |
| Grafting of posterior tibial flap |
Reconstruction using posterior tibial artery fasciocutaneous flap |
| Grafting of tarsal or metatarsal |
Grafting of phalanges of foot |
| Grahamella |
Genus Bartonella (organism) |
| Grahamella peromysci |
Bartonella peromysci |
| Grahamella species |
Genus Bartonella (organism) |
| Grahamella talpae |
Bartonella peromysci |
| Grahamellosis |
Bartonellosis |
| hyphe Gram positif ramifié et filamenteux |
Gram-positive branched filamentous bacilli present (finding) |
| grande multiparité associée à un problème anténatal |
Grand multipara |
| Grandparent of subject |
Grandparent |
| Granuloma of lacrimal passages |
Lacrimal sac granuloma |
| granulome d'une plaie chirurgicale |
Granuloma of surgical wound (finding) |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.8.8-SNAPSHOT
|
FHIR Version n/a
User: [n/a]